Join the club for FREE to access the whole archive and other member benefits.

Demis Hassabis

Artificial intelligence researcher, neuroscientist, founder and CEO of DeepMind

Demis Hassabis co-founded DeepMind in 2010 after successful careers in academia and computer game development. A child chess prodigy, he designed and programmed the multi-million selling, award-winning game Theme Park at the age of 17. After graduating from Cambridge University, he founded pioneering videogames firm Elixir Studios and completed a PhD in cognitive neuroscience at UCL. The journal Science listed his research on imagination and memory as one of 2007’s top ten breakthroughs. Demis is a Fellow of the Royal Society, Royal Academy of Engineering and the Royal Society of Arts. In 2017 he featured in the Time 100 list of most influential people, and in 2018 he was awarded a CBE for services to science and technology.

Visit website: https://deepmind.com/about#leadership

 demishassabis

 demishassabis

See also: Company DeepMind - Company developing AI systems for solving problems.

Details last updated 30-Jan-2020

Demis Hassabis is also referenced in the following:

Isomorphic Labs

Discovering new drugs with AI-first approach

Demis Hassabis News

Isomorphic Labs rethinks drug discovery with no labs, just AI

Isomorphic Labs rethinks drug discovery with no labs, just AI

Endpoints News - 12-Dec-2024

This aims to reduce development time but faces challenges in proving real-world success

Nobel prize awarded for AI breakthrough in protein science

Nobel prize awarded for AI breakthrough in protein science

BBC - 08-Oct-2024

AI transforms how we understand and target proteins

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

pharmaphorum - 08-Jan-2024

Their AlphaFold engine models proteins could lead to faster and more effective treatments

Google's parent company launched Isomorphic Labs to discover new drugs using AI

Google's parent company launched Isomorphic Labs to discover new drugs using AI

TechCrunch - 04-Feb-2022

Building from Deepmind's AI research, Isomorphic promises medical breakthroughs

Deepmind's AI program has decoded a protein mystery

Deepmind's AI program has decoded a protein mystery

Guardian - 30-Nov-2020

Will help in developing designer meds, better crops & 'green enzymes' to counter pollution

Human-like intuition and creativity, now exhibited by DeepMind's AlphaZero

Human-like intuition and creativity, now exhibited by DeepMind's AlphaZero

YAHOO! - 07-Dec-2018

This improvisation was regarded as historical 'turning point' for AI

AI researchers sign pledge against killer robots

AI researchers sign pledge against killer robots

Guardian - 18-Jul-2018

Over 150 firms agreed against developing A.I-based weapons, governments should be next